Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase.
作者信息
Aslan Burcu, Hubner Stefan Edward, Fox Judith A, Taverna Pietro, Wierda William G, Kornblau Steven M, Gandhi Varsha
机构信息
Department of Experimental Therapeutics.
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.
出版信息
Haematologica. 2022 Jan 1;107(1):292-297. doi: 10.3324/haematol.2021.279158.
Abstract
摘要
Zotero 插件